CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Classification
Class II
Status
Terminated
Lot
Lot: G1822K, Exp. Date:5/31/2023.
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Preferred Pharmaceuticals, Inc. — Class II Recall | MedicineWatch US